Variant report

Variant	nsv1002342
Chromosome Location	chr2:50879012-50948407
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:211)
CpG islands
(count:122)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:211 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr2:50919262-50919518	K562	blood:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
2	CEBPB	chr2:50919242-50919552	HepG2	liver:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
3	CEBPB	chr2:50890728-50891191	HepG2	liver:	n/a	chr2:50890749-50890760 chr2:50891044-50891055
4	CEBPB	chr2:50919241-50919557	IMR90	lung:	n/a	chr2:50919400-50919413 chr2:50919400-50919411
5	CHD2	chr2:50947884-50948198	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTCF	chr2:50902100-50902250	HCT-116	colon:	n/a	n/a
7	CTCF	chr2:50902100-50902250	Hela-S3	cervix:	n/a	n/a
8	CTCF	chr2:50902140-50902290	GM12871	blood:	n/a	n/a
9	CTCF	chr2:50902060-50902290	GM12864	blood:	n/a	n/a
10	CTCF	chr2:50886104-50886220	NHEK	skin:	n/a	n/a
11	CTCF	chr2:50902180-50902330	GM12871	blood:	n/a	n/a
12	CTCF	chr2:50902100-50902250	GM12864	blood:	n/a	n/a
13	CTCF	chr2:50902080-50902230	HL-60	blood:	n/a	n/a
14	CTCF	chr2:50889588-50889678	GM19239	blood:	n/a	n/a
15	CTCF	chr2:50902220-50902370	A549	lung:	n/a	n/a
16	CTCF	chr2:50902200-50902350	GM12869	blood:	n/a	n/a
17	CTCF	chr2:50902013-50902311	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr2:50902076-50902365	GM12878	blood:	n/a	n/a
19	CTCF	chr2:50902140-50902290	HRPEpiC	eye:	n/a	n/a
20	CTCF	chr2:50902182-50902235	LNCaP	prostate:	n/a	n/a
21	CTCF	chr2:50902119-50902292	GM19240	blood:	n/a	n/a
22	CTCF	chr2:50902100-50902250	GM12870	blood:	n/a	n/a
23	CTCF	chr2:50889598-50889668	NHEK	skin:	n/a	n/a
24	CTCF	chr2:50902176-50902276	GM10248	blood:	n/a	n/a
25	CTCF	chr2:50902163-50902293	Gliobla	brain:	n/a	n/a
26	CTCF	chr2:50902100-50902250	HepG2	liver:	n/a	n/a
27	CTCF	chr2:50902120-50902270	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr2:50902080-50902230	NHEK	skin:	n/a	n/a
29	CTCF	chr2:50902091-50902331	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr2:50889589-50889673	MCF-7	breast:	n/a	n/a
31	CTCF	chr2:50902080-50902230	GM12869	blood:	n/a	n/a
32	CTCF	chr2:50902197-50902266	Medullo	brain:	n/a	n/a
33	CTCF	chr2:50889625-50889634	Gliobla	brain:	n/a	n/a
34	CTCF	chr2:50902120-50902270	GM12878	blood:	n/a	n/a
35	CTCF	chr2:50902200-50902350	HRE	kidney:	n/a	n/a
36	CTCF	chr2:50902100-50902250	GM12874	blood:	n/a	n/a
37	CTCF	chr2:50889605-50889670	MCF-7	breast:	n/a	n/a
38	CTCF	chr2:50902124-50902313	A549	lung:	n/a	n/a
39	CTCF	chr2:50902100-50902250	GM12872	blood:	n/a	n/a
40	CTCF	chr2:50902120-50902270	HBMEC	blood vessel:	n/a	n/a
41	CTCF	chr2:50902100-50902250	HFF-Myc	foreskin:	n/a	n/a
42	CTCF	chr2:50902106-50902258	A549	lung:	n/a	n/a
43	CTCF	chr2:50902100-50902250	NHEK	skin:	n/a	n/a
44	CTCF	chr2:50902155-50902320	GM12878	blood:	n/a	n/a
45	CTCF	chr2:50902140-50902290	GM12872	blood:	n/a	n/a
46	CTCF	chr2:50902080-50902230	GM12875	blood:	n/a	n/a
47	CTCF	chr2:50902100-50902250	WERI-Rb-1	eye:	n/a	n/a
48	CTCF	chr2:50902120-50902270	GM12874	blood:	n/a	n/a
49	CTCF	chr2:50902081-50902284	HepG2	liver:	n/a	n/a
50	CTCF	chr2:50902100-50902250	K562	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:50884252-50884302	Jurkat	blood:	n/a
2	chr2:50884693-50884743	SK-N-MC	brain:	n/a
3	chr2:50884693-50884743	NH-A	brain:	n/a
4	chr2:50884252-50884302	NH-A	brain:	n/a
5	chr2:50884252-50884302	NB4	blood:	n/a
6	chr2:50884693-50884743	GM12892	blood:	n/a
7	chr2:50884693-50884743	MCF-7	breast:	n/a
8	chr2:50884252-50884302	HRE	kidney:	n/a
9	chr2:50884252-50884302	CMK	blood:	n/a
10	chr2:50884693-50884743	AG04450	lung:	fetal
11	chr2:50884252-50884302	HAEpiC	amniotic membrane:	n/a
12	chr2:50884252-50884302	SK-N-SH_RA	brain:	n/a
13	chr2:50884252-50884302	GM12892	blood:	n/a
14	chr2:50884252-50884302	ECC-1	luminal epithelium:	n/a
15	chr2:50884693-50884743	ProgFib	skin:	n/a
16	chr2:50884693-50884743	HepG2	liver:	n/a
17	chr2:50884693-50884743	U87	brain:	n/a
18	chr2:50884693-50884743	HCM	heart:	n/a
19	chr2:50884693-50884743	BE2_C	brain:	n/a
20	chr2:50884252-50884302	A549	lung:	n/a
21	chr2:50884693-50884743	HIPEpiC	eye:	n/a
22	chr2:50884693-50884743	A549	lung:	n/a
23	chr2:50884252-50884302	HCPEpiC	choroid plexus:	n/a
24	chr2:50884252-50884302	MCF-7	breast:	n/a
25	chr2:50884252-50884302	AG10803	skin:	n/a
26	chr2:50884693-50884743	AG09309	skin:	n/a
27	chr2:50884252-50884302	AG04450	lung:	fetal
28	chr2:50884693-50884743	HCT-116	colon:	n/a
29	chr2:50884693-50884743	AG10803	skin:	n/a
30	chr2:50884252-50884302	GM06990	blood:	n/a
31	chr2:50884252-50884302	MCF10A-Er-Src	breast:	n/a
32	chr2:50884252-50884302	T-47D	breast:	n/a
33	chr2:50884252-50884302	HCM	heart:	n/a
34	chr2:50884252-50884302	GM12878	blood:	n/a
35	chr2:50884693-50884743	RPTEC	kidney:	n/a
36	chr2:50884252-50884302	HUVEC	blood vessel:	n/a
37	chr2:50884252-50884302	Caco-2	colon:	n/a
38	chr2:50884252-50884302	Hela-S3	cervix:	n/a
39	chr2:50884693-50884743	Jurkat	blood:	n/a
40	chr2:50884252-50884302	HNPCEpiC	eye:	n/a
41	chr2:50884693-50884743	SK-N-SH_RA	brain:	n/a
42	chr2:50884252-50884302	NT2-D1	testis:	n/a
43	chr2:50884693-50884743	PrEC	prostate:	n/a
44	chr2:50884693-50884743	HEK293	kidney:	embryo
45	chr2:50884252-50884302	GM12891	blood:	n/a
46	chr2:50884252-50884302	BJ	skin:	n/a
47	chr2:50884693-50884743	HL-60	blood:	n/a
48	chr2:50884252-50884302	LNCaP	prostate:	n/a
49	chr2:50884252-50884302	U87	brain:	n/a
50	chr2:50884252-50884302	SK-N-SH	brain:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:50883231..50884999-chr2:50887642..50889397,2	MCF-7	breast:
2	chr2:50946676..50947176-chr20:60981159..60981778,2	MCF-7	breast:
3	chr2:50884335..50886694-chr2:50887318..50889235,3	K562	blood:
4	chr2:50909775..50912434-chr2:50920496..50923402,2	MCF-7	breast:
5	chr2:50884111..50885778-chr2:50886770..50888521,2	MCF-7	breast:
6	chr2:50884111..50885778-chr2:50886770..50888521,2	MCF-7	breast:
7	chr2:50884335..50886694-chr2:50887318..50889235,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000216191	TF binding region
NRXN1	TF binding region
ENSG00000216191	CpG island
NRXN1	CpG island
ENSG00000216191	chromatin interactions
ENSG00000179915	chromatin interactions

Extended variants
information (count: 2439 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:2439 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs858956	chr2:50879012-50879013	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs149259490	chr2:50879017-50879018	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs184041710	chr2:50879019-50879020	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs533289513	chr2:50879029-50879030	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs564461560	chr2:50879052-50879053	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs566711547	chr2:50879081-50879082	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs189167274	chr2:50879083-50879084	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs547097171	chr2:50879105-50879106	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs77404298	chr2:50879111-50879112	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs535908490	chr2:50879158-50879159	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs181843635	chr2:50879181-50879182	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs575194134	chr2:50879216-50879217	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs76642247	chr2:50879237-50879238	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs558021459	chr2:50879250-50879251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs186903000	chr2:50879274-50879275	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs540449537	chr2:50879304-50879305	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs561857742	chr2:50879306-50879307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs374988215	chr2:50879336-50879337	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs72885663	chr2:50879337-50879338	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs77023952	chr2:50879360-50879361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs562473591	chr2:50879412-50879413	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs531594077	chr2:50879480-50879481	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs532945691	chr2:50879518-50879519	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs140649066	chr2:50879540-50879541	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs76879398	chr2:50879577-50879578	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs560459793	chr2:50879580-50879581	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs369005905	chr2:50879621-50879622	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs138154375	chr2:50879647-50879648	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs192104470	chr2:50879659-50879660	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs535598079	chr2:50879667-50879668	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550626507	chr2:50879728-50879729	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs7590532	chr2:50879732-50879733	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs369736303	chr2:50879738-50879739	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs11901620	chr2:50879755-50879756	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs558076611	chr2:50879798-50879799	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs143622331	chr2:50879804-50879805	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs549258488	chr2:50879805-50879806	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs534462891	chr2:50879822-50879823	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs182391300	chr2:50879835-50879836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs116227918	chr2:50879914-50879915	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs544360891	chr2:50879921-50879922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs147225639	chr2:50879950-50879951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs569162079	chr2:50879967-50879968	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs372953037	chr2:50879983-50879984	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs185964330	chr2:50879997-50879998	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs12995518	chr2:50880025-50880026	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs200226731	chr2:50880070-50880071	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs542879423	chr2:50880082-50880083	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs551737839	chr2:50880097-50880098	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs72618641	chr2:50880119-50880120	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Basal cell lymphoma	21115979	CNVD
Cognitive impairment	21505072	CNVD
Psychiatric disorder	19734545	CNVD
Autism	20844286	CNVD
Schizophrenia	20838587	CNVD
Schizophrenia	20718829	CNVD
Autism	19218893	CNVD
Autism	22209245	CNVD
Neuropsychiatric disorder	21827697	CNVD
Schizophrenia	22118685	CNVD
Autism	20663923	CNVD
Schizophrenia	21285140	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21990379	CNVD
Schizophrenia	22885689	CNVD
Autism	20964600	CNVD
Schizophrenia	19521646	CNVD
Attention deficit hyperactivity disorder	22214315	CNVD
Chronic motor tic disorder	22214315	CNVD
Schizophrenia	22214315	CNVD
Mental retardation	19896112	CNVD
Acute myeloid leukemia	20729466	CNVD
Bipolar disorder	19114987	CNVD
Autism	20841430	CNVD

Chromatin state (count:229 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:50876200-50879200	Weak transcription	Brain Cingulate Gyrus	brain
2	chr2:50876400-50879800	Enhancers	HMEC	breast
3	chr2:50877000-50879200	Enhancers	Brain Germinal Matrix	brain
4	chr2:50878000-50879400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr2:50878000-50879800	Enhancers	NHEK	skin
6	chr2:50878200-50880000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr2:50878600-50879200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
8	chr2:50878800-50879400	Enhancers	Brain Hippocampus Middle	brain
9	chr2:50878800-50879400	Enhancers	Fetal Brain Female	brain
10	chr2:50878800-50879800	Enhancers	Cortex derived primary cultured neurospheres	brain
11	chr2:50879000-50879200	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr2:50879000-50879400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr2:50879000-50879400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr2:50879000-50879400	Weak transcription	Brain Substantia Nigra	brain
15	chr2:50879000-50879800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr2:50879200-50879400	Enhancers	HSMMtube	muscle
17	chr2:50879400-50879600	Enhancers	Brain Cingulate Gyrus	brain
18	chr2:50879400-50879800	Enhancers	Brain Substantia Nigra	brain
19	chr2:50879400-50885000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr2:50879800-50884400	Weak transcription	NHEK	skin
21	chr2:50879800-50888600	Weak transcription	Cortex derived primary cultured neurospheres	brain
22	chr2:50880000-50884600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr2:50884400-50886800	Enhancers	NHEK	skin
24	chr2:50884600-50885000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:50884600-50886400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr2:50884800-50885200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr2:50885000-50886400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr2:50885000-50888600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr2:50885200-50888400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr2:50885400-50886400	Enhancers	HMEC	breast
31	chr2:50885600-50886400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr2:50885800-50886400	Enhancers	H9 Cell Line	embryonic stem cell
33	chr2:50885800-50886400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr2:50886000-50886200	Enhancers	iPS-18 Cell Line	embryonic stem cell
35	chr2:50886000-50886400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr2:50886200-50888600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
37	chr2:50886400-50890400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr2:50886800-50890600	Weak transcription	NHEK	skin
39	chr2:50888400-50890800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr2:50888600-50889200	Enhancers	iPS-18 Cell Line	embryonic stem cell
41	chr2:50888600-50889400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
42	chr2:50888600-50889600	Enhancers	Cortex derived primary cultured neurospheres	brain
43	chr2:50888600-50890400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr2:50889000-50889200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr2:50889000-50889400	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr2:50889400-50890800	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr2:50890400-50890800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr2:50890400-50899200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr2:50890600-50891400	Enhancers	NHEK	skin
50	chr2:50890800-50891000	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links